Order results by:
| Issue | Title | |
| Vol 4, No 1 (2008) | ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| "... Guidelines are discussed. Problem of statin choice and problem of equivalence of generic drugs to original ..." | ||
| Vol 5, No 6 (2009) | STATIN GENERICS: EFFICACY AND SAFETY RATIO | Abstract similar documents |
| V. P. Voronina, A. A. Serazhim, A. V. Zagrebelnyi, S. Yu. Martsevich, S. A. Shalnova | ||
| "... Statin usage for primary and secondary prevention of cardiovascular diseases is focused. Rational ..." | ||
| Vol 18, No 1 (2022) | Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data) | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, A. V. Zagrebelnyy, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. S. Nekoshnova, I. V. Budaeva, S. V. Blagodatskikh, B. B. Aslanova | ||
| "... inertia of doctors regarding titration of statin doses, and in some cases caused by the choice of drugs ..." | ||
| Vol 10, No 5 (2014) | STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE | Abstract similar documents |
| L. N. Malay | ||
| "... Statins, the most common drugs for reduction in lipid levels, are “strategic” medicinal products ..." | ||
| Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
| "... .3%, statins – up to 45.6%. Despite of no changes registered in prescription rate of the ACE inhibitors, marked ..." | ||
| Vol 7, No 6 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA | Abstract similar documents |
| V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich | ||
| "... изучению эффективности и переносимости оригинальных и воспроизводимых препаратов симвастатина включены 30 ..." | ||
| Vol 16, No 4 (2020) | Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice | Abstract similar documents |
| D. V. Nebieridze, N. M. Akhmedzhanov, S. A. Davitashvili, A. S. Lishuta, A. S. Safaryan | ||
| "... the possible benefits of statin therapy in fixed doses for primary and secondary prevention of cardiovascular ..." | ||
| Vol 18, No 2 (2022) | The problem of choice: original drug or generic? Emphasis on rosuvastatin | Abstract similar documents |
| O. A. Polyakova, O. D. Ostroumova | ||
| "... , rosuvastatin is one of the most potent and widely prescribed statins. Considering that most of the clinically ..." | ||
| Vol 1, No 2 (2005) | STATINES IN PREVENTION AND TREATMENT OF ATHEROSCLEROSIS CONNECTED DISEASES: EFFICIENCY AND SAFETY | Abstract similar documents |
| Y. A. Karpov | ||
| "... , aswell as problems of statin treatment safety. The choice of the drug must be based on clinical research ..." | ||
| Vol 9, No 4 (2013) | REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER) | Abstract similar documents |
| S. Yu. Martsevich, O. V. Gaisenok, S. G. Tripkosh, Yu. V. Lukina, A. V. Zagrebel’nyy | ||
| "... Aim. To analyze tactics of statins use in patients with high cardiovascular risk on the base ..." | ||
| Vol 10, No 6 (2014) | DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY) | Abstract similar documents |
| A. I. Ershova, A. N. Meshkov, S. S. Yakushin, M. M. Loukianov, K. A. Moseychuk, S. Yu. Martsevich, A. V. Zagrebelnyy, A. N. Vorobyev, K. G. Pereverzeva, E. A. Pravkina, A. N. Kozminskiy, S. A. Boytsov | ||
| "... hypercholesterolemia were classified as patients at high or very high cardiovascular risk, but statins were recommended ..." | ||
| Vol 12, No 5 (2016) | Statins in Secondary Prevention of Atrial Fibrillation | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin | ||
| "... group II (n=32) did not take statins. The duration of follow-up was 4 years. The evolution of the AF ..." | ||
| Vol 7, No 3 (2011) | STROKE PREVENTION IN INTERNIST PRACTICE | Abstract similar documents |
| D. A. Napalkov, A. V. Zhilenko | ||
| "... guidelines. Modern pharmacotherapy includes antiaggregants or anticoagulants, statins, and antihypertensive ..." | ||
| Vol 2, No 2 (2006) | PROBLEM OF TREATMENT WITH STATINS IN RUSSIA: WILL GENERICS HELP? | Abstract similar documents |
| S. Y. Martsevich | ||
| "... The article underlines necessity of statins treatment for patients with high risk of cardio ..." | ||
| Vol 13, No 2 (2017) | SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova | ||
| "... .39%, statins – 69.45%). When assessing prescribed doses of drugs, an increase in a number of their higher doses ..." | ||
| Vol 12, No 5 (2016) | Endothelium Protective Function of Statins in Men and Women with Coronary Atherosclerosis | Abstract similar documents |
| M. V. Klimushina, N. G. Gumanova, A. Ju. Gorshkov, N. E. Gavrilova, V. A. Metel'skaja, S. A. Boytsov | ||
| "... . Negative correlation between the statins receiving and serum endothelin level was found in men (r=-0.11; p ..." | ||
| Vol 14, No 4 (2018) | Statin Therapy and Cognitive Impairment: Benefit or Harm? | Abstract similar documents |
| O. D. Ostroumova, E. V. Chikh, E. V. Rebrova, A. Yu. Ryazanova | ||
| "... Statins are now widely used drugs for the treatment of dyslipidemia, effective drugs for lowering ..." | ||
| Vol 11, No 4 (2015) | TREATMENT OF PATIENTS WITH SEVERE DYSLIPIDEMIA IN REAL CLINICAL PRACTICE | Abstract similar documents |
| V. A. Korneva, T. Yu. Kuznetsova, E. S. Karpova, K. I. Rupasova | ||
| "... cholesterol >9 mmol/l) the frequency of statins prescription in 2009-2012 was 70%. In 28.9% of the patients ..." | ||
| Vol 5, No 4 (2009) | PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| "... The definition of primary prevention of cardiovascular diseases is presented. Statins preventive ..." | ||
| Vol 16, No 5 (2020) | Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
| "... Aim. To perform a pharmacoeconomical assessment of the use of generic statin drugs in patients ..." | ||
| Vol 17, No 1 (2021) | Optimization of the Statin Therapy Algorithm in Outpatient Practice: Adherence and Economic Benefits | Abstract similar documents |
| S. A. Davitashvili, D. V. Nebieridze, N. M. Akhmedzhanov, A. S. Lishuta, A. S. Safaryan | ||
| "... of a titration-free statin therapy regimen. Material and methods. Ambulatory patients (n=300) with a high ..." | ||
| Vol 8, No 4 (2012) | EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS | Abstract similar documents |
| I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze | ||
| "... and, first of all beta-blockers, ACE inhibitors, diuretics, and statins on bone are presented. Mode of action ..." | ||
| Vol 14, No 6 (2018) | Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues | Abstract PDF (Eng) similar documents |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan | ||
| "... on a low number of patients taking statins, and even less – reaching recommended target cholesterol levels ..." | ||
| Vol 10, No 5 (2014) | STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE | Abstract similar documents |
| V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev | ||
| "... been focused on statins use. Evidence base of this drugs class use in the perioperative period serves ..." | ||
| Vol 15, No 2 (2019) | Assessment of the Adequacy of Drug Choice in Patients with Acute Myocardial Infarction According to the PROFILE-IM Registry | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov | ||
| "... by prescribing beta-blockers (BB), angiotensin converting enzyme inhibitors (ACEI) and statins. This is reflected ..." | ||
| Vol 11, No 3 (2015) | ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I | Abstract similar documents |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta | ||
| "... was significantly above the target and varied from 5.82 to 6.10 mmol/L. At that, statins had not been prescribed ..." | ||
| Vol 18, No 6 (2022) | The Pathogenetic Basis of the Action of Bempedoic Acid | Abstract similar documents |
| A. S. Petrosyan, R. S. Rud', P. P. Polyakov, A. Kh. Kade, S. A. Zanin | ||
| "... metabolic pathway as statins, but at an earlier stage. According to this, it is possible that medications ..." | ||
| Vol 11, No 5 (2015) | Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis | Abstract similar documents |
| N. E. Gavrilova, V. A. Metelskaya, E. B. Yarovaya, N. V. Gomyranova, S. A. Boytsov | ||
| "... Aim. To assess of lipid-lowering therapy with statins in very high cardiovascular risk patients ..." | ||
| Vol 11, No 5 (2015) | Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation | Abstract similar documents |
| E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. Yu. Panasyuk, A. S. Avdeeva, A. V. Volkov, I. G. Kirillova, E. I. Markelova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov | ||
| "... proatherogenic blood profile was observed in both groups. The patients of MTX group more frequently took statins ..." | ||
| Vol 11, No 1 (2015) | MYOPATHY AS A SIDE EFFECT OF STATIN THERAPY: MECHANISMS OF DEVELOPMENT AND PROSPECTS FOR TREATMENT | Abstract similar documents |
| O. M. Drapkina, E. M. Chernova | ||
| "... Statins are lipid-lowering drugs with proven efficacy that reduce cardiovascular risk and are well ..." | ||
| Vol 12, No 3 (2016) | THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? | Abstract PDF (Eng) similar documents |
| S. N. Bel'diev | ||
| "... to use statins in patients with cardiovascular diseases and concomitant chronic liver diseases. Analysis ..." | ||
| Vol 11, No 2 (2015) | HYPOLIPIDEMIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN 2004-2010 ACCORDING TO THE PROGNOZ IBS REGISTER | Abstract similar documents |
| S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
| "... Aim. To evaluate the frequency of prescription, efficacy and patients adherence to statin therapy ..." | ||
| Vol 8, No 4 (2012) | UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina | ||
| "... in patients with CVD risk factors, of course, are statins. The results of multi-center studies showing ..." | ||
| Vol 9, No 5 (2013) | TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2) | Abstract similar documents |
| S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
| "... hospital. In specialized hospital the rate of aspirin use increased by 30%, statins - by 80%, beta-blockers ..." | ||
| Vol 11, No 2 (2015) | THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT? | Abstract similar documents |
| S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov | ||
| "... Aim. To study the opinion of doctors about the possibility of statins prescription to patients ..." | ||
| Vol 19, No 2 (2023) | Statins and highly sensitive cardiac troponins: cardiotoxicity or cross-reactivity? | Abstract similar documents |
| A. M. Chaulin, D. V. Duplyakov | ||
| "... To date, hypolipidemic drugs of the statin group are among the most popular therapeutic agents ..." | ||
| Vol 9, No 4 (2013) | STATINS AND THE RISK OF DIABETES MELLITUS | Abstract similar documents |
| O. M. Drapkina | ||
| "... Randomized controlled trials have clearly demonstrated the efficacy of statins in reduction ..." | ||
| Vol 9, No 5 (2013) | THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION | Abstract similar documents |
| R. N. Adzhiev, M. S. Safarova, M. V. Ezhov | ||
| "... , Post-CABG, TNT) and meta-analyzes on the role of statins, prescribed before and after coronary artery ..." | ||
| Vol 9, No 4 (2013) | STATINS IN PREVENTION OF ISCHEMIC STROKE | Abstract similar documents |
| A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk | ||
| "... The evidence base of statin therapy in primary and secondary prevention of ischemic stroke ..." | ||
| Vol 8, No 3 (2012) | STATINS AND MYOPATHY: MOLECULAR MECHANISMS | Abstract similar documents |
| O. M. Drapkina, E. M. Chernova, O. N. Korneeva | ||
| "... The safety of statin therapy is considered. In particular the reasons of a complication ..." | ||
| Vol 19, No 6 (2023) | New possibilities for lipid level control using inclisiran — prospects for interaction between a cardiologist and a neurologist | Abstract similar documents |
| A. B. Skiba, M. V. Menzorov, V. D. Puchek, I. M. Buchin, I. I. Polyakov, E. N. Menzorova | ||
| "... in the modern paradigm for dyslipidemia treatment from high-intensity statin therapy to high-intensity lipid ..." | ||
| Vol 9, No 3 (2013) | STATINS AND RISK OF INFECTIOUS DISEASES | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| "... Besides hypolipidemic effect statins demonstrate some not-lipid (pleotropic) ones. Special ..." | ||
| Vol 9, No 2 (2013) | STATIN SAFETY REVISITED DATA | Abstract similar documents |
| O. M. Drapkina | ||
| "... Questions of statins use in liver diseases are discussed. Data from clinical studies on statins ..." | ||
| Vol 4, No 3 (2008) | DYNAMICS OF THE HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION DURING ATORVASTATIN THERAPY | Abstract similar documents |
| E. S. Kozlova, E. E. Galaktionova, F. A. Nemchuk, Yu. M. Lopatin | ||
| "... лечения (базовая антиаритмическая терапия с дополнительным назначением аторвастатина Липтонорм (ОАО ..." | ||
| Vol 17, No 1 (2021) | Lipid Clinic is an Efficacious Model of Preventive Medicine | Abstract PDF (Eng) similar documents |
| A. V. Blokhina, A. I. Ershova, A. N. Meshkov, A. S. Limonova, V. I. Mikhailina, O. M. Drapkina | ||
| "... statin therapy was recommended for 32% of patients, and combined lipid-lowering therapy – for 14 ..." | ||
| Vol 13, No 1 (2017) | SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION | Abstract similar documents |
| S. N. Bel'diev | ||
| "... Russian physicians often afraid to use statins in patients with high cardiovascular risk ..." | ||
| Vol 19, No 5 (2023) | Nephroprotective effect of atorvastatin at a dose of 80 mg in patients with ST-segment elevation myocardial infarction with an invasive treatment strategy | Abstract similar documents |
| A. D. Gavrilko, E. M. Mezhonov, S. V. Shalaev, D. V. Krasheninin | ||
| "... ). The control group was not prescribed statins before the intervention. In both groups, further statin therapy ..." | ||
| Vol 10, No 5 (2014) | RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME | Abstract similar documents |
| N. V. Perova, V. A. Metelskaya | ||
| "... recommendations are presented as well as the application of risk categories for the choice of strategy ..." | ||
| Vol 5, No 3 (2009) | CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE | Abstract PDF (Eng) similar documents |
| I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva | ||
| "... intake and not appropriate BP self-monitoring. Low frequency of statins therapy and non-targeted ..." | ||
| Vol 13, No 2 (2017) | STATINS AND THEIR INTERACTION WITH MODEL CELL MEMBRANES ACCORDING TO THE DATA OF NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY | Abstract similar documents |
| I. A. Latfullin, L. F. Galiullina, G. S. Musabirova, O. V. Aganova, Z. F. Kim, A. V. Aganov, V. V. Klochkov | ||
| "... interatomic distances between the atoms of statins and micelles. Material and methods. Nuclear magnetic ..." | ||
| Vol 13, No 2 (2017) | OBJECTIVE AND SUBJECTIVE FACTORS OF MEDICAL DRUG CHOICE | Abstract similar documents |
| E. B. Babanskaya, L. V. Menshikova | ||
| "... Aim. To analyze the factors of medical choice in the prescription of medicinal drug (MD ..." | ||
| Vol 10, No 4 (2014) | QUALITY ASSESSMENT OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION WITHOUT CONCOMITANT CARDIOVASCULAR DISEASES AS A PART OF OUTPATIENT RECVASA REGISTER | Abstract similar documents |
| A. V. Zagrebelnyy, S. Yu. Martsevich, M. M. Loukianov, E. A. Pravkina, A. N. Vorobyev, S. S. Yakushin, S. A. Boytsov | ||
| "... register RECVASA, emphasizing whether the choice of antihypertensive drugs (AHD) is in line with current ..." | ||
| Vol 15, No 1 (2019) | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength | Abstract similar documents |
| I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova | ||
| "... of cardiovascular drugs, such as statins, beta-blockers, ACE inhibitors, diuretics, calcium antagonists and nitrates ..." | ||
| Vol 19, No 2 (2023) | Outpatient Practice of Lipid-Lowering Therapy Prescription (According to the ARGO-3 Study) | Abstract similar documents |
| M. V. Ezhov, N. M. Akhmedzhanov, T. E. Kolmakova, A. V. Tyurina, A. I. Martynov | ||
| "... ) was studied based on the results of a questionnaire. Results. Monotherapy with statins was prescribed in 55 ..." | ||
| Vol 5, No 6 (2009) | STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY? | Abstract similar documents |
| I. N. Grigorieva, Y. M. Pozdnyakov | ||
| "... ), non-alcoholic steatohepatitis (NASH) and hypercholesterolemia (HCE) with statins and ursodeoxycholic ..." | ||
| Vol 7, No 2 (2011) | LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE | Abstract similar documents |
| A. V. Susekov, N. V. Khokhlova | ||
| "... The evidences for statin use in cardiology are presented. Especially hypolipidemic efficacy ..." | ||
| Vol 8, No 5 (2012) | LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS | Abstract similar documents |
| A. N. Meshkov | ||
| "... of the study of rosuvastatin therapy efficacy , in comparison with other statins, received in controlled ..." | ||
| Vol 14, No 3 (2018) | HYPOLIPIDEMIC THERAPY IN STROKE PREVENTION: EXISTING STANDARDS, EVIDENCE-BASED MEDICINE DATA AND REAL PRACTICE | Abstract similar documents |
| O. V. Gaisenok, A. N. Rozhkov, A. S. Lishuta | ||
| "... . The issues of lipid-lowering therapy with statins in the aspect of stroke prevention are discussed ..." | ||
| Vol 2, No 4 (2006) | POSTMENOPAUSAL METABOLIC SYNDROME: CORRECTION OF AUTONOMIC NERVOUS SYSTEM DISBALANCE WITH COMBINATION OF ACE-INHIBITOR AND STATIN | Abstract similar documents |
| I. V. Logacheva, E. N. Shustova, E. V. Kulinich | ||
| "... (ACE inhibitor and statin), not only have antihypertensive and hypolipidemic action, but also reduce ..." | ||
| Vol 21, No 2 (2025) | Rhabdomyolysis as a rare severe complication of statin therapy: differential diagnosis in real clinical practice (a clinical case) | Abstract similar documents |
| A. V. Melekhov, S. V. Borisovskaya, N. S. Gavrilina, I. I. Gaponova, I. G. Nikitin, O. A. Ettinger | ||
| "... common adverse events when using statins, they do not pose a real threat in most cases. Rhabdomyolysis ..." | ||
| Vol 6, No 6 (2010) | NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION | Abstract similar documents |
| E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya | ||
| "... Background. Effects of statins on cardiovascular end points are well-known. To study the impact ..." | ||
| Vol 10, No 3 (2014) | THE SAFETY OF STATINS: WHAT A PHYSICIAN NEEDS TO KNOW | Abstract similar documents |
| D. A. Napalkov | ||
| "... Various aspects of the safety of statins in clinical practice are discussed: hepatotoxicity ..." | ||
| Vol 3, No 1 (2007) | MICROCIRCULATORY ISCHEMIA AND STATINS: LESSONS OF INTERVENTION CARDIOLOGY | Abstract similar documents |
| An. A. Alexandrov, I. I. Tchukaeva | ||
| "... . Therapy by statins can be beneficial for patients with microcirculatory ischemia. ..." | ||
| Vol 11, No 6 (2015) | Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon? | Abstract similar documents |
| I. A. Latfullin, L. F. Galiullina, I. Z. Rakhmatullin, V. V. Klochkov, A. V. Aganov | ||
| "... A hypothesis that possible pleiotropic features of different statins could be explained ..." | ||
| Vol 10, No 2 (2014) | STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov | ||
| "... for statins use. Material and methods. Patients (n=262, age 60.1±8.9 years) took statins for secondary ..." | ||
| Vol 6, No 4 (2010) | EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK | Abstract similar documents |
| N. V. Perova, E. I. Sokolov, G. N. Shchukina, V. A. Metelskaya | ||
| "... Current views on the efficacy criteria of hyperlipidaemia treatment with statins are considered ..." | ||
| Vol 6, No 6 (2010) | THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina | ||
| "... Basic principles of beta-blockers choice strategy are presented. Attention is focused on the facts ..." | ||
| Vol 1, No 3 (2005) | RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS | Abstract similar documents |
| D. A. Anichkov, N. A. Shostak | ||
| "... . The perspectives of treatments with statins in RA are given. Results of clinical trials on statin effects ..." | ||
| Vol 13, No 4 (2017) | GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS | Abstract similar documents |
| M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava | ||
| "... lipid-lowering therapy and can be considered as a predictor of resistance to statins. ..." | ||
| Vol 15, No 4 (2019) | Antihypertensive Drug Utilization in Two Districts of Northern Cyprus | Abstract PDF (Eng) similar documents |
| M. Tamirci, R. Demirdamar | ||
| "... the antihypertensive drug choices and good prescribing principles. The prescribed antihypertensive agents were ..." | ||
| Vol 14, No 6 (2018) | Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan | ||
| "... Aim. To study adherence to treatment with generic statins prescribed to patients with high and very ..." | ||
| Vol 11, No 5 (2015) | Three-year dynamics and unsolved problems of lipid-lowering therapy | Abstract similar documents |
| V. A. Sergeeva | ||
| "... . Сохраняются недостатки в модификации образа жизни (диета, курение, гиподинамия). Гиполипидемические препараты ..." | ||
| Vol 13, No 6 (2017) | SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS | Abstract similar documents |
| I. N. Ozerova, V. A. Metelskaya, N. E. Gavrilova | ||
| "... lipoproteins in men and women with coronary atherosclerosis treated with statins depending on low density ..." | ||
| Vol 10, No 4 (2014) | STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN | Abstract similar documents |
| N. G. Gogolashvili | ||
| Vol 11, No 3 (2015) | THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov | ||
| "... using Propensity Score Matching. Material and methods. 262 patients aged 60.1±8.9 years, taking statins ..." | ||
| Vol 5, No 2 (2009) | OBSERVATIONAL TRAILS IN LIPIDOLOGY | Abstract similar documents |
| S. A. Shalnova | ||
| "... and observational trails are presented. The trail data on statins efficacy and safety are held up as a model. ..." | ||
| Vol 9, No 2 (2013) | MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER) | Abstract similar documents |
| S. Yu. Martsevich, O. V. Gaysenok, S. G. Tripkosh, A. V. Zagrebelnyy, Yu. V. Lukina | ||
| "... in the main group compared to the control (p<0.05). Statins were constantly taken by 34% of patients ..." | ||
| Vol 14, No 5 (2018) | Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
| Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal | ||
| Vol 9, No 6 (2013) | APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY | Abstract similar documents |
| D. A. Sychev, G. N. Shuev, A. B. Prokofiev | ||
| "... polipeptide) in the development of statin induced myopathy is considered. Possible tactics of statin dose ..." | ||
| Vol 6, No 6 (2010) | COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE | Abstract similar documents |
| S. V. Shalaev, Z. M. Safiullina, L. V. Kremneva, O. V. Abaturova | ||
| "... function, ability to reduce the blood level of C-reactive protein are important in the statins mode ..." | ||
| Vol 17, No 5 (2021) | A Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases | Abstract PDF (Eng) similar documents |
| Yu. V. Bulaeva, E. A. Naumova, O. N. Semenova, T. V. Kanaeva, K. A. Popov, А. R. Tyapayeva | ||
| "... to the atherosclerosis development and the effect of statin therapy on atherosclerotic plaque, on adherence to long-term ..." | ||
| Vol 9, No 2 (2013) | TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) | Abstract similar documents |
| S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
| "... of cardiovascular complications (antiplatelets, β-blockers, ACE inhibitors, statins) were not often prescribed ..." | ||
| Vol 13, No 4 (2017) | HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE? | Abstract similar documents |
| I. S. Yavelov, M. V. Zhatkina, O. M. Drapkina, A. Yu. Gorshkov, N. O. Myasnikova | ||
| "... statins in high doses before percutaneous coronary interventions (PCI) are presented in the review ..." | ||
| Vol 8, No 6 (2012) | ASSESSMENT OF CORONARY ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH FIVE YEAR HISTORY OF MYOCARDIAL INFARCTION DEPENDING ON THE STATIN THERAPY COMPLIANCE | Abstract similar documents |
| A. I. Chesnikova, V. A. Safronenko, A. V. Hripun | ||
| "... of myocardial infarction (MI) depending on the statin therapy compliance. Material and methods. Patients (n=31 ..." | ||
| Vol 12, No 2 (2016) | LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY) | Abstract similar documents |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta | ||
| "... назначал терапию розувастатином, выбирая дозу препарата по своему усмотрению. Повторное определение уровня ..." | ||
| Vol 21, No 2 (2025) | A randomized controlled trial of statin therapy effect on androgen status and erectile function in men with high and very high cardiovascular risk (TRISTAN): rationale and study protocol | Abstract similar documents |
| K. P. Raevskii, O. Yu. Nesterova, A. A. Strigunov, M. E. Chaliy, A. V. Kadrev, A. G. Plisyuk, A. A. Kamalov, Ya. A. Orlova | ||
| "... Aim. To study the effect of different intensities of statin therapy on androgen status ..." | ||
| Vol 10, No 5 (2014) | CHOICE OF THE INITIAL TREATMENT FOR MILD TO MODERATE ARTERIAL HYPERTENSION IN MOSCOW PRIMARY PRACTICE | Abstract similar documents |
| S. V. Gatsura, O. A. Gatsura, A. N. Golosova | ||
| "... Aim. To assess the choice of initial pharmacotherapy of uncomplicated mild to moderate arterial ..." | ||
| Vol 15, No 2 (2019) | Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics | Abstract similar documents |
| G. P. Arutyunov, S. A. Boytsov, M. I. Voyevoda, V. S. Gurevich, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, I. V. Sergiyenko, M. V. Shestakova, A. S. Aliyeva, N. M. Akhmedzhanov, M. G. Bubnova, А. S. Galyavich, I. G. Gordeyev, M. V. Ezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Ya. A. Orlova, A. V. Panov, S. A. Sayganov, V. V. Skibitskiy, E. I. Tarlovskaya, S. A. Urazgildeyeva, Yu. Sh. Khalimov | ||
| "... the triglycerides concentration is their level more than 2.3 mmol/l. Statins are drugs of choice aimed to decrease ..." | ||
| Vol 4, No 4 (2008) | LOVASTATIN EFFECT ON VASCULAR REMODELING AND MYOCARDIAL SYSTOLIC AND DIASTOLIC FUNCTION IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. S. Kerimkulova, A. M. Noruzbaeva, O. S. Lunegova, B. Z. Imanov, M. A. Pavlenko, A. E. Mirrahimov, I. JU. Gottfried, E. M. Mirrahimov | ||
| Vol 9, No 3 (2013) | INTEGRATED ASSESSMENT OF STATIN-ASSOCIATED MUSCLE DAMAGE PREDICTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| V. I. Petrov, O. N. Smuseva, Yu. V. Solovkina | ||
| "... Aim. To assess the risk factors of statin-associated muscle damage in patient with ischemic heart ..." | ||
| Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
| A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
| "... ), statins, sodium-glucose transporter type 2 inhibitors (SGLT-2i) and oral anticoagulants (OAC). Results ..." | ||
| Vol 2, No 3 (2006) | ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? | Abstract similar documents |
| I. A. Latfullin, A. A. Podolskaya | ||
| "... антитромбоцитарных свойств статинов, их связь со стимуляцией продукции оксида азота, мощного эндогенного ..." | ||
| Vol 14, No 3 (2018) | THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova | ||
| "... schemes and the preferred doses of statins and antiplatelet agents depending on the localization ..." | ||
| Vol 16, No 5 (2020) | Clinical and Pharmacological Approaches to the Prescription of Centrally Acting Antihypertensive Drugs for Uncontrolled Arterial Hypertension | Abstract similar documents |
| A. V. Strygin, B. E. Tolkachev, A. O. Strygina, A. M. Dotsenko | ||
| "... that, definite expert consensus regarding optimal choice of antihypertensive drugs to manage these patients have ..." | ||
| Vol 14, No 2 (2018) | THE ANALYSIS OF DIFFERENCES IN DOCTORS PREFERENCES IN THE PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS IN FOUR REGIONS OF THE FAR EASTERN FEDERAL DISTRICT | Abstract similar documents |
| M. S. Soboleva, Е. E. Loskutova | ||
| "... Aim. To study regional features and preferences of specialists in the choice of drug therapy ..." | ||
| Vol 13, No 1 (2017) | EVALUATION OF TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION BEFORE REFERENCE EVENT AND BEFORE DISCHARGE FROM THE HOSPITAL: REGISTER DATA (KHABAROVSK CITY). PART 2 | Abstract similar documents |
| L. N. Malay, S. Yu. Martsevich, L. V. Solokhina, Y. M. Bukhonkina, K. E. Poshatayev, N. B. Garayeva, A. Ya. Letskin | ||
| "... .8%). Results. Before reference AMI a frequency of administration of statins was 13.7%, angiotensin-renin ..." | ||
| Vol 7, No 3 (2011) | REDUCTION DEGREE OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL LEVELS ACCORDING TO DIFFERENT DOSES OF STATINS; ITS EFFECT ON THE RISK OF ISCHEMIC HEART DISEASE ACUTE EPISODES DEPENDING ON TREATMENT DURATION; AND RISK OF ISCHEMIC AND THROMBOEMBOLIC STROKE. COMMENT ON THE PAPER OF LAW M.R., WALD N.J., RUDNICKA A.R. QUANTIFYING EFFECT OF STATINS ON LOW DENSITY LIPOPROTEIN CHOLESTEROL, ISCHAEMIC HEART DISEASE, AND STROKE: SYSTEMATIC REVIEW AND META-ANALYSIS. BMJ 2003; 326:1423-1427 | Abstract similar documents |
| N. V. Perova | ||
| "... Comparative dose-dependent ability of different statins to lower serum low-density lipoproteins ..." | ||
| Vol 2, No 1 (2006) | DEGENERATIVE AORTIC STENOSIS: PATHOGENESIS AND NEW PRINCIPLES OF TREATMENT | Abstract similar documents |
| O. V. Andropova, V. N. Anokhin | ||
| Vol 20, No 3 (2024) | NLRP3 Inflammasome — a new universal target of asymptomatic hyperuricemia and gout management | Abstract similar documents |
| P. A. Lebedev, L. T. Volova, N. K. Osina, E. V. Paranina | ||
| "... with cardiovascular outcomes. New clinically relevant pleotorpic effects of statins, sodium-glucose cotransporter-2 ..." | ||
| 1 - 100 of 1003 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
